Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Bioxytran, Inc. (BIXT) had Income from Continuous Operations of $-2.12M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.12M |
|
-- |
|
-- |
|
$1.84M |
|
$-1.84M |
|
$-0.28M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
|
Income from Continuous Operations |
$-2.12M |
$-2.12M |
|
$-2.12M |
|
$-1.84M |
|
$-1.83M |
|
91.84M |
|
91.84M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.51M |
|
-- |
|
$0.15M |
|
$0.66M |
|
$3.25M |
|
-- |
|
-- |
|
$3.25M |
|
$-2.63M |
|
$-2.74M |
|
$-2.59M |
|
108.15M |
|
| Cash Flow Statement Financials | |
$-0.53M |
|
$-0.02M |
|
$1.05M |
|
$0.01M |
|
$0.51M |
|
$0.50M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.16 |
|
-- |
|
-- |
|
-- |
|
-0.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.58% |
|
77.59% |
|
-322.39% |
|
81.93% |
|
$-0.02 |
|
$-0.01 |
|
$-0.01 |
|